Skip to main content
Premium Trial:

Request an Annual Quote

New Products Posted to GenomeWeb This Week: Fluxion, Mobidiag, Quanterix, More

Fluxion ERASE-Seq NGS Liquid Biopsy Analysis Service

Fluxion Biosciences said that its ERASE-Seq bioinformatics solution can now be used for variant calling from a wide range of targeted cancer panels. The analysis tool was previously limited to use on Fluxion's Spotlight 59 cancer panel. Users can now apply ERASE-Seq to Swift Biosciences' Accel Amplicon 56G panel and Illumina's TruSight Tumor 15 panel using bioinformatic analyses that are already cloud accessible. Other custom and commercial panels that users are intereseted in can also be added following validation testing by Fluxion, the company said.

Mobidiag Novodiag

Mobidiag launched the Novodiag, a fully automated solution for syndromic and targeted testing for infectious disease. Novodiag allows direct analysis of a patient sample in a disposable cartridge and delivers results in a few hours, according to the firm. It also allows for the detection of antibiotic resistance. The PCR and microarray-based instrument is aimed at small- to medium-sized clinical microbiology labs with lower throughput requirements.

Quanterix SR-X Ultra-Sensitive Biomarker Detection System

Quanterix has announced the commercial availability of its SR-X Ultra-Sensitive Biomarker Detection system, powered by the firm's Simoa technology. The research-use-only system lets users design assays to detect both proteins and nucleic acids directly from blood, as well as several other complex sample types. The SR-X enables measurement of nucleic acid levels, including miRNA, without using PCR. The platform is designed to detect up to six biomarkers per sample, with low volume requirements, the company said.

For more new products and services, please visit the New Products page on our website.

Filed under